90281-65-5 Usage
Uses
Used in Pharmaceutical Applications:
(S-benzylcysteinyl)glycine benzyl ester is used as a therapeutic agent for its potential to modulate oxidative stress and inflammation. Its antioxidant properties make it a promising candidate for the development of treatments targeting various diseases and conditions.
Used in Biochemical Research:
In the field of biochemistry, (S-benzylcysteinyl)glycine benzyl ester is used as a research tool to study the regulation of cellular redox balance and its impact on cellular processes.
Used in Cardiovascular Disease Mitigation:
(S-benzylcysteinyl)glycine benzyl ester is used as a mitigating agent for cardiovascular disease, potentially helping to reduce the effects of this condition through its modulation of oxidative stress and inflammation.
Used in Neurodegenerative Disorder Research:
(S-benzylcysteinyl)glycine benzyl ester is also used in the research of neurodegenerative disorders, where it may contribute to understanding the underlying mechanisms and development of therapeutic strategies to combat such diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 90281-65-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,2,8 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 90281-65:
(7*9)+(6*0)+(5*2)+(4*8)+(3*1)+(2*6)+(1*5)=125
125 % 10 = 5
So 90281-65-5 is a valid CAS Registry Number.
90281-65-5Relevant academic research and scientific papers
Artificial model for cystathionine β-synthase: Efficient β-replacement reaction with thiols employing a novel pyridoxal model compound having an imidazole function
Miyashita, Kazuyuki,Murafuji, Hidenobu,Iwaki, Hiroshi,Yoshioka, Eito,Imanishi, Takeshi
, p. 4873 - 4879 (2007/10/03)
As a second-generation pyridoxal model compound for cystathionine β-synthase, we designed a novel model compound having an ionophore function and an imidazole function, application of which to the β-replacement reaction with various thiols smoothly took place to give S-substituted cysteines. Peptides having a serine-O-carbonate residue at the N-terminal position were also converted to the corresponding peptides having an S-substituted cysteine residue under the catalytic conditions of the novel pyridoxal model compound.
